Detalles de la búsqueda
1.
Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
Cancer
; 129(14): 2256-2265, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151113
2.
The value of new drugs for advanced prostate cancer.
Cancer
; 127(18): 3457-3465, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34062620
3.
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
N Engl J Med
; 379(8): 753-763, 2018 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30110579
4.
Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.
Oncologist
; 25(3): e439-e450, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162822
5.
Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Cancer
; 124(10): 2104-2114, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29505670
6.
Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.
BMC Cardiovasc Disord
; 16: 13, 2016 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26769473
7.
The relationship between Lp(a) and CVD outcomes: a systematic review.
Lipids Health Dis
; 15: 95, 2016 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184891
8.
Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer.
J Natl Compr Canc Netw
; 13(3): 303-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25736007
9.
Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.
BMC Health Serv Res
; 15: 245, 2015 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26104784
10.
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer with PD-L1 ≥ 1 %: A subgroup analysis from the EMPOWER-Lung 3 part 2 trial.
Lung Cancer
; 193: 107821, 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38820979
11.
Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer.
Cancer
; 119(20): 3619-28, 2013 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23913478
12.
Aiding the Adoption of Master Protocols by Optimizing Patient Engagement.
Ther Innov Regul Sci
; 57(6): 1136-1147, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37615880
13.
Regulatory and HTA Considerations for Development of Real-World Data Derived External Controls.
Clin Pharmacol Ther
; 114(2): 303-315, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37078264
14.
Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions.
Clin Pharmacol Ther
; 114(2): 325-355, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079433
15.
Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial.
J Thorac Oncol
; 18(6): 755-768, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37001859
16.
Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020-2025.
Leuk Lymphoma
; 63(1): 54-63, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34510995
17.
Awareness and Availability of Routine Germline BRCA1/2 Mutation Testing in Patients with Advanced Breast Cancer in Germany.
Breast Care (Basel)
; 17(1): 40-46, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35350106
18.
Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
Sci Rep
; 12(1): 17670, 2022 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36271096
19.
Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer.
Adv Ther
; 39(10): 4645-4662, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948845
20.
Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions.
Front Pharmacol
; 13: 1031992, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36339622